A list of article published by Charles "Snuffy" Myers, MD

  • Black Men - October 2023

    This issue talks about Black Ment and Prostate Cancer>

    Prostate cancer is a significant health concern affecting men worldwide, with disparities in its impact evident across different demographic … more

  • Metastatic Hormone-Sensitive - January - February 2023

    This issue covers some of the advances made in treating men with metastatic prostate cancer who have not yet received hormonal therapy.In patients with high-volume metastatic disease, the current … more

  • Chemotherapy - November - December 2022

    It is now customary to treat men with newly diagnosed advanced prostate cancer with Lupron and Docetaxel. In a major advance, we now know adding the androgen blocking drugs abiraterone or … more

  • Immunotherapy - October 2022

    Immunotherapy has an interesting status in prostate cancer treatment research. It has attracted some of the best minds in prostate cancer research and motivated innovative laboratory and clinical … more

  • Testing - July 2022

    The processes involved in cancer treatment are and the greater the odds you will defeat your enemy. As you read this issue, consider how you might use additional testing to improve your treatment … more

  • Theranostics - May 2022

    This issue is devoted to the first successful theranostic treatment for prostate cancer.

    The strategy involves a two step approach and derives it's name from the combination of the terms … more

  • Radiation Therapy - March 2022


    This issue offers a concise overview of the major trends in radiation therapy. This is timely as some of these advances are already altering treatment in a major way.

    From the patient's … more

  • Immuno-oncology - December 2021

    Tags: prostatepedia

    We only have one FDA-approved immunotherapy for prostate cancer, Provenge (sipuleucel-T). However, that may be about to change. Research on how to harness the immune system to treat cancer is … more

  • Chemotherapy - September 2021

    This issue is focused on when to use Taxotere (docetaxel) chemotherapy. Taxotere (docetaxel) is most commonly used after hormonal therapy options have lost their effectiveness.

    However, the CHAARTED … more